Federal Register / Vol. 62, No. 188 / Monday, September 29, 1997 / Notices 50955

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Laura Oliven, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington,

D.C. 20503.

Dated: September 22, 1997.

Jane Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–25727 Filed 9–26–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Health Resources

and Services Administration (HRSA)

publishes abstracts of information

collection requests under review by the

Office of Management and Budget, in

compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35). To request a copy of the

clearance requests submitted to OMB for

review, call the HRSA Reports

Clearance Office on (301)–443–1129.

The following request has been

submitted to the Office of Management

and Budget for review under the

Paperwork Reduction Act of 1995:

Proposed Project: Ryan White

Comprehensive AIDS Resources and

Emergency (CARE) Act Women’s

Initiatives (WIN)—New

The Health Resources and Services

Administration’s HIV-AIDS Bureau

proposes to collect information about

HIV-related services provided to women

of child-bearing age and their children.

Information will be collected annually

from eight grantees funded under

Sections 2671 and 2691 of the Public

Health Service Act and 320 of the

individual and institutional providers

who provide services to HIV-infected

pregnant women in the grantee service

areas. The eight funded sites will collect

the information in person or by

telephone from the providers in their

service areas, and forward the data

collection forms to a HRSA contractor.

There are no plans to collect or transmit

the data electronically.

The purpose is to document current

care system characteristics and facilitate

planning for services to women with

HIV and their children. The information

will be used within and outside HRSA

to inform the administration and

Congress about HIV counseling and

testing services for pregnant women,

services and referral resources for

pregnant women with HIV,

antiretroviral therapies, and outreach

related to perinatal HIV transmission

reduction. Annual burden estimates are

as follows:

Type of respondent Number of respondents

Responses

per respondent

Burden hours

per response

Total burden

hours

Providers ........................................................................................................... 320 1 .75 240

Funded Sites .................................................................................................... 8 40 1 320

Total ....................................................................................................... 328 ........................ ........................ 560

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Laura Oliven, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington,

D.C. 20503.

Dated: September 22, 1997.

Jane Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–25729 Filed 9–26–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Magnesium in Coronaries

(MAGIC).

Date: October 15–16, 1997.

Time: 7:00 p.m.

Place: Holiday Inn Gaithersburg, 2

Montgomery Village Avenue, Gaithersburg,

Maryland 20814.

Contact Person: Anthony M. Coelho, Ph.D.,

Two Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7956,

(301) 435–0288.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of SEP: Demonstration and

Education Research Applications (R18).

Date: October 28, 1997.

Time: 8:30 a.m.

Place: Washington National Airport Hilton,

2399 Jefferson Davis Highway, Arlington,

Virginia 22202.

Contact Person: Louise Corman, Ph.D.,

Two Rockledge Center, Room 7180, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0270.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: September 22, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–25704 Filed 9–26–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice
50956 Federal Register / Vol. 62, No. 188 / Monday, September 29, 1997 / Notices

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Initial Review Group and

Special Emphasis Panel meetings.

Purpose/Agenda: To review and evaluate

grant applications and contract proposals.

Name of Committee: Human Development

Research Subcommittee.

Date: October 6, 1997.

Time: 8:30 a.m.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Human Development).

Date: October 6, 1997.

Time: 2:00 p.m.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Basic Behavioral

Science Research Subcommittee.

Date: October 7–8, 1997.

Time: 8:30 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20818.

Contact Person: Mark Swieter, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Telephone (301) 443–2620.

Name of Committee: Epidemiology and

Prevention Research Subcommittee.

Date: October 7–9, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Basic Behavioral Science).

Date: October 8, 1997.

Time: 11:00 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20818.

Contact Person: Khursheed Asghar, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Telephone (301) 443–2620.

This notice is being published less than 15

days prior to the meetings due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

Name of Committee: Neuropharmacology

Research Subcommittee.

Date: October 14–16, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Syed Husain, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: NIDA Special

Emphasis Panel (Centers).

Date: October 16, 1997.

Time: 8:30 a.m.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Mary C. Custer, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Neurophysiology and

Neuroanatomy Research Subcommittee.

Date: October 20–21, 1997.

Time: 8:30 a.m.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Molecular, Cellular

and Chemical Neurobiology Research

Subcommittee.

Date: October 22–24, 1997.

Time: 8:30 a.m.

Place: Marriott Hotel of New Orleans, 555

Cannal Street, New Orleans, LA 70130.

Contact Person: Rita Liu, Ph.D., Scientific

Review Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–22,

Telephone (301) 443–9042.

Name of Committee: Health Service

Research Subcommittee.

Date: October 28–29, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: Treatment Research

Subcommittee.

Date: October 28–30, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Treatment).

Date: October 29, 1997.

Time: 9:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Khursheed Asghar, Ph.D,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: NIDA Special

Emphasis Panel (Contract Review).

Date: October 30, 1997.

Time: 9:00 a.m.

Place: Parklawn Bldg., 3rd Floor

Conference Center, 5600 Fishers Lane,

Rockville, MD 20857.

Contact Person: Mr. Lyle Furr, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–42,

Telephone (301) 443–1644.

Name of Committee: NIDA Special

Emphasis panel (RFA DA–98–001—

Neurobiological Substrates of Cognitive

functioning in Drug Abuse).

Date: November 17–18, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

room 10–22, Telephone (301) 443–9042.

Name of Committee: AIDS Biomedical and

Clinical Research Subcommittee.

Date: November 18–19, 1997.

Time: 8:30 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20818.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

The meetings will be closed in accordance

with provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. The

applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, disclosure of

which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278; Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs)

Dated: September 22, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–25699 Filed 9–26–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 United States Code

Appendix 2), notice is hereby given of

the following National Institute of Child

Health and Human Development

Special Emphasis Panel (SEP) meeting: